Prevalence of Haemarthrosis and Clinical Impact on The Musculoskeletal System in People With Haemophilia in The United Kingdom; Evaluation of UK National Haemophilia Database and Haemtrack Patient Reported Data.
暂无分享,去创建一个
H. Xiang | B. Palmer | D. Stephensen | E. Horn | Martin Scott | H. Siddle | R. Walwyn | G. Chapman | M. Richards | R. Wilkins | A. Redmond
[1] P. Chowdary. Extended half-life recombinant products in haemophilia clinical practice - Expectations, opportunities and challenges. , 2019, Thrombosis research.
[2] M. Ragni,et al. Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.
[3] G. Dolan,et al. Achieving the unimaginable: Health equity in haemophilia , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.
[4] A. Abad,et al. Developing a new scoring scheme for the Hemophilia Joint Health Score 2.1 , 2019, Research and practice in thrombosis and haemostasis.
[5] M. Scott,et al. Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.
[6] G. Castaman,et al. Hemophilia A and B: molecular and clinical similarities and differences , 2019, Haematologica.
[7] L. V. van Vulpen,et al. Joint disease in haemophilia: Pathophysiology, pain and imaging , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.
[8] E. Rodríguez‐Merchán. Management of Hemophilic Arthropathy of the Ankle. , 2017, Cardiovascular & hematological disorders drug targets.
[9] G. Dolan,et al. The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[10] S. Frostick,et al. Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[11] J. Oldenburg,et al. European retrospective study of real‐life haemophilia treatment , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[12] B. Bartels,et al. Using routine Haemophilia Joint Health Score for international comparisons of haemophilia outcome: standardization is needed , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.
[13] F. Sofi,et al. Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A , 2015, Haematologica.
[14] J. Oldenburg. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. , 2015, Blood.
[15] A. Gringeri,et al. The burden of bleeding in haemophilia: is one bleed too many? , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.
[16] P. Mannucci,et al. Is haemophilia B less severe than haemophilia A? , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[17] J. Mahlangu,et al. Guidelines for the management of hemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[18] M. Skinner. WFH: Closing the global gap – achieving optimal care , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.
[19] L. Mantovani,et al. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) , 2011, Journal of thrombosis and haemostasis : JTH.
[20] M. Clerici,et al. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile , 2010, Journal of thrombosis and haemostasis : JTH.
[21] M. Morfini,et al. Efficacy and safety of secondary prophylactic vs. on‐demand sucrose‐formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13‐month crossover study , 2010, Journal of thrombosis and haemostasis : JTH.
[22] G. Dolan,et al. Changing patterns of bleeding in patients with severe haemophilia A , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.
[23] K. Mulder,et al. Orthopaedic management of haemophilia arthropathy of the ankle , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[24] Alan R. Cohen,et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.
[25] B. Feldman,et al. Hemophilia joint health score reliability study , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[26] F. Lafeber,et al. Pathogenesis of haemophilic arthropathy , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[27] L. Valentino,et al. Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. , 2004, Blood.
[28] K. Pasi,et al. Haemophilias A and B , 2003, The Lancet.
[29] J. Bijlsma,et al. Blood-induced joint damage: longterm effects in vitro and in vivo. , 2003, The Journal of rheumatology.
[30] J. Bijlsma,et al. Blood-induced joint damage: a canine in vivo study. , 1999, Arthritis and rheumatism.
[31] R. G. Macfarlane,et al. Haemophilia and Related Conditions: A Survey of 187 Cases , 1958, British journal of haematology.
[32] A. Satterfield,et al. TREATMENT , 1924, California and western medicine.